Company News
19 - 20 August 2010
Bangalore, India
Panel Discussion
- Sourcing the right partners, Sponsors – vendor partnerships
Shashidhar Rao, R. Mohan, Marcus Hompesch
Friday, August 20, 12:00 p.m.
17 - 23 July 2010
Copenhagen, Denmark
Session
- Early Indications for Clinical Efficacy of Diabetes Drugs in Develpment in Phase 1 Studies: How?
Marcus Hompesch
Monday, July 19, 1:00 p.m. - 2:00 p.m.
Poster Hall, Poster Board No. Mon 175
25 - 29 June 2010
Orlando, Fl
Booth: # 1764
-
Human Hyaluronidase Coinjection Accelerates Insulin Pharmacokinetics and Glucodynamics of 3 Rapid Insulin Analogs
Linda Morrow, Douglas Muchmore, Marcus Hompesch, Elizabeth Luddington , Daniel Vaughn
Monday, June 28, 4:30 p.m. - 4:45 p.m.
Session: Insulin Delivery Systems, Room 311
- Coadministration of Liraglutide with Insulin Detemir Does Not Affect the Pharmacokinetics of Either Drug
Linda Morrow, Marcus Hompesch, Heidi Guthrie, Denise Chang, William Lyness, DJ Chatterjee
Abstract No. 834ADA10D1; Poster Hall C Publication No. 653-p
- Canagliflozin, a Novel Inhibitor of Sodium Glucose Co-transporter 2, Improved Glucose Control in Subjects with Type 2 Diabetes and Was Well Tolerated
Sue Sha, Damayanthi Devineni, Atalanta Ghosh, David Polidori, Marcus Hompesch, Sabine Arnolds, Linda Morrow, Heike Spitzer, Joanne Blake, David Wexler, Yvonne Tan, Kris Smulders, Keith Demarest, Paul Rothenberg
Abstract No. 2433ADA10D1; Poster Hall C Publication No. 568-p
- Canagliflozin Improves Glycemic Control in Subjects With Type 2 Diabetes (T2D) Not Optimally Controlled on Stable Doses of Insulin
Sherwyn Schwartz, Linda Morrow, Marcus Hompesch, Damayanthi Devineni, Donna Skee, An Vandebosch, Joe Murphy, Michael Pfeifer
Abstract No. 3223ADA10D1; Poster Hall C Publication No. 564-p
- Accelerated Insulin PK and Improved Glycemic Control in T2DM Patients by Coinjection of Prandial Insulin with Hyaluronidase
Marcus Hompesch, Douglas Muchmore, Linda Morrow, Elizabeth Luddington, Daniel Vaughn
Abstract No. 1445ADA10D1; Poster Hall C Publication No. 387-pp
- A Phase 1, Open-Label Study of the Effect of Albuterol or Fluticasone on the Pharmacokinetics of Inhaled Technosphere® Insulin Inhalation Powder in Healthy Subjects
Robert Baughman, James Cassidy, Nikhil Amin, Marcus Hompesch, Mark Marino, Pamela Haworth, Peter Richardson
Abstract No.1764ADA10D1; Poster Hall C Publication No. 528-p
- Human Regular Insulin U-500 Shows Prolonged Time-to-Peak Effect and Longer Duration of Action vs Human Regular Insulin U-100 in Healthy Obese Subjects
Jeffrey A. Jackson, Amparo de la Peña, Linda A. Morrow, Helle Linnebjerg, Honghua H. Jiang, Khin Win, Linda L. Wolka,
Marcus Hompesch, Matthew Riddle
Abstract No.248ADA10D1LB; Poster Hall C Publication No. 14-LB
- Sitagliptin and Metformin Increase Active GLP-1 by Complementary Mechanism in Treatment-Naive Patients with Type 2 Diabetes
Elizabeth Migoya, Jutta Miller, Wen-Lin Luo, Edward O'Neill,
Linda Morrow, Maria Gutierrez, Aubrey Stoch, John A. Wagner
Abstract No.1636ADA10D1; Poster Hall C Publication No. 0572-p
published January - July 2010
Tour de Cure 2010, San Diego
Congratulations, Team Profil Peddlers!
We joined hundreds of Red Riders who as patients with Diabetes share a similar story and showed what courage it takes to live with Diabetes.
We brought family, friends and co-workers to the Tour de Cure, San Diego on Saturday, April 17th .
Thank you for your outstanding support in the fight against Diabetes!
Our team raised an amazing total of more than $10,000 to help change the future of Diabetes. We had 31 Profil Peddlers and 10 volunteers!
Because of your hard work and dedication to the Profil team and the American Diabetes Association, we were able to make a difference in the lives of 23.6 million Americans living with Diabetes.
Thanks to the generosity and support of our contributors, the American Diabetes Association can fund much-needed community-based education programs, protect the rights of people with Diabetes and fund critical research for a cure.
Together we can find better treatments for Diabetes.
published April - July 2010
American Diabetes Association
"Team Profil" takes the Tour de Cure - Join us
The San Diego Tour de Cure boasts one of the most scenic and beautiful routes in California.
Cyclists of all levels of expertise are sure to enjoy this unique day of fun, fitness, friendship and the personal satisfaction of completing a ride that moves us closer to finding a better treatment for Diabetes.
All routes offer spectacular views of the ocean and mountain ranges of North County San Diego.
Whether you ride 30 miles or take on challenge of a full Century we are certain you will fall in love with San Diego all over again!
Profil is proud to announce a team of riders locally - "Team Profil"
Take the ride of your life! Join our team!
Whether you are a first-time rider or an avid cyclist, we have a route that is perfect for you.
For more information click here.
Hear the spot
published March-April 2010
ISCR 2010 presentation
At this year's annual meeting of the Indian Society for Clinical Research (ISCR) in Bangalore, India, on January 7-9, Dr. Marcus Hompesch gave an invited presentation on challenges during early phase cincial development of Diabetes drugs.
The presentation was very well received and led to interesting discussions with both academic researchers and scientists from the bio-pharmaceutical industry.
Historically, there has been very limited Phase I study work completed by Indian bio-pharmaceutical companies. However, with an increasing number of innovator compounds advancing from pre-clinical to clinical stage in India, there is growing interest in the early phase clinical research process. Of particular interest was the case study presented of a first-in-man study conducted in the disease population (Diabetes).
The presentation is available upon request,
please contact:
Profil Institute for Clinical Research Inc.
Dr. Marcus Hompesch
President – CEO
science@profil-research.com
published February 2010
As part of our mission to find better treatments for Diabetes and Obesity, we are proud to support others in our community who encourage lifestyle changes to improve their health.
One such organization is insulinDependence.org, whose mission is to inspire people with Diabetes to set personal fitness goals, educate them on adaptive management strategies through hands-on experience, and equip them to explore their individual capacities.
We are sponsoring a group of Type I diabetics who participated in January's Carlsbad Marathon as Glucomotive, under the umbrella of insulinDependence. This is the second year we have partnered with this organization and we encourage you to join in supporting them.
Please click here for more information!
published January 2010
Profil scientists present internationally
Profil scientists have presented their work at several recent conferences, including the European Association for the Study of Diabetes (EASD) in Vienna, Austria, and the International Diabetes Federation (IDF) in Montreal, Quebec.
The most recent presentations were at the Diabetes Technology Meeting in San Francisco, CA and included three poster presentations:
1. Hompesch, Marcus, et al.
Evaluation of Performance of a Continuous Glucose Measurement Device in Subjects with Type 1 and Type 2 Diabetes by means of a Glucose Clamp (Hypoglycemia Performance Feasibility)
2. Judge, Kevin, et al.
Comparative Accuracy of Continuous Glucose Monitoring using Glucose Binding Protein (GBP) in a 12 hour Feasibility Study
3. Muchmore, Douglas, et al.
Reduced Variability of Insulin Lispro Injected with Hyaluronidase
and one oral presentation:
1. Judge, Kevin.
First Report of the Accuracy of Continuous Glucose Monitoring Using Glucose-Binding Protein (GBP).
For more details of these presentations, please contact:
Profil Institute for Clinical Research, Inc.
Dr. Linda Morrow
Medical Director – COO
profilnews@profil-research.com
published December 2009
Profil Plays Santa!
Profil's staff helped to spread holiday cheer by contributing to the Chula Vista Police Activities League annual Toy Drive.
In just two days, we were able to gather 92 new toys for the children of Chula Vista!
Additional cash donations were also raised for this especially deserving group in our own backyard.
published December 2009
Profil walkers raise over $ 2,000 for JDRF
(Juvenile Diabetes Research Foundation)
Be a part of the cure!
Team Profil participated in the JDRF Walk to Cure Diabetes on November 8th 2009 at the UCSD campus.
Team Profil was proud to be a part of the nearly 5,000 walkers - the largest walk in the history of JDRF San Diego!
Fundraising efforts by the teammates helped raise $1,075 to support JDRF's mission to cure Diabetes and its complications through the support of research.
The management team is proud to announce that we will match the money raised by our walkers.
published November 2009
RSSDI 2009 presentation
At this year's meeting of the Research Society for the Study of Diabetes in India (RSSDI), in Ahmedabad, India, Profil scientists presented a poster on the automated glucose clamp technique.
The poster presentation was perceived very well and led to interesting discussions with academic researchers and scientists from the bio-pharmaceutical industry.
The abstract that was submitted is available upon request,
please contact:
Profil Institute for Clinical Research Inc.
Dr. Marcus Hompesch
President – CEO
profilnews@profil-research.com
published November 2009